Breast Cancer News

Cancer drugs that received approval based on increased OS compared with other measures had the lowest median annual cost, according to a research letter published in JAMA Internal Medicine.

Individuals diagnosed with cancer during incarceration or within a year after release from prison have a higher risk for cancer mortality than those never incarcerated, according to a study from Yale Cancer Center.

This year’s San Antonio Breast Cancer Symposium spotlighted practice-changing research in several subtypes.

Long travel times to facilities offering mammography substantially limited accessibility to breast cancer screening, particularly for women living in rural areas, according to data published in the Journal of the National Cancer Institute.

SAN ANTONIO — The addition of carboplatin to sequential taxane-anthracycline neoadjuvant chemotherapy significantly improved outcomes among patients with triple-negative breast cancer, according to study results.

SAN ANTONIO — Sacituzumab govitecan prolonged survival compared with physician’s choice of therapy among patients with heavily pretreated breast cancer, according to results presented at San Antonio Breast Cancer Symposium.

In this video, Sara M. Tolaney, MD, MPH, discusses recent findings from DESTINY-Breast03 that assessed the use of fam-trastuzumab deruxtecan-nxki in previously treated patients with HER2-positive unresectable or metastatic breast cancer.

In this video, Sara M. Tolaney, MD, MPH, discusses recent findings examining the use of capivasertib and fulvestrant in patients with aromatase inhibitor-resistant hormone receptor-positive, HER2-negative advanced breast cancer.

A new clinical practice guideline from the Endocrine Society recommends treatment with IV bisphosphonates or denosumab in addition to adequate hydration for adults with moderate hypercalcemia of malignancy.

Certain fungal species in tumors may be associated with worse cancer outcomes, according to a study conducted by researchers at Weill Cornell Medicine and Duke University and published in the journal Cell.